Skip to content

Farydak

Published: July 26, 2026Updated: July 26, 2026

Farydak (panobinostat) is a prescription brand-name medication classified as a histone deacetylase (HDAC) inhibitor. It is used in combination with other drugs to treat multiple myeloma in patients who have received at least two prior therapies including bortezomib and an immunomodulatory agent. This medication works by affecting cell cycle regulation and inducing apoptosis in cancer cells.

Quick summary

Farydak is an HDAC inhibitor used to treat multiple myeloma in patients who have tried at least two prior therapies.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

RxNorm
1603356
Generic
Farydak
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Farydak is indicated for the treatment of multiple myeloma in adult patients who have received at least two prior lines of therapy, including bortezomib and an immunomodulatory agent. It is used in combination with bortezomib and dexamethasone.

Farydak is a histone deacetylase (HDAC) inhibitor that works by blocking enzymes responsible for removing acetyl groups from histone proteins. This alteration in gene expression helps regulate cell growth, induce apoptosis (programmed cell death), and inhibit tumor cell proliferation.

Farydak carries a Boxed Warning for severe diarrhea and cardiac toxicity, including fatal cardiac events. Close monitoring of blood counts, electrolytes, and cardiac function is required during treatment. Common side effects include fatigue, nausea, edema, and decreased appetite. It may cause fetal harm and should not be used during pregnancy.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy